US-China Trade Update: Imports, Exports, Fentanyl Flows, and Beyond

Why It Matters

Accurate trade and security data will shape the agenda of the upcoming US‑China summit, influencing tariff decisions, tech restrictions, and law‑enforcement cooperation. The briefing’s evidence‑based approach helps separate policy options from partisan narratives.

Key Takeaways

• New 2025 US-China trade data shows modest export growth
• Fentanyl shipments from China to US remain significant concern
• Export‑control tensions intensify amid escalating tech rivalry
• Briefing separates facts from political narratives on trade
• Insights expected to influence Trump‑Xi summit agenda

Pulse Analysis

The United States and China stand at a pivotal crossroads as the next presidential summit approaches, and the Peterson Institute’s briefing offers a data‑driven snapshot of that relationship. Chad Bown’s 2025 trade‑flow analysis reveals that while overall import volumes have steadied, U.S. exports to China are inching upward, suggesting a modest rebalancing after years of tariff‑induced volatility. This nuanced picture challenges the simplistic narrative of a one‑sided trade war and provides policymakers with concrete metrics to calibrate future tariff adjustments and negotiate market‑access provisions.

Beyond commerce, the briefing highlighted the persistent public‑health threat posed by fentanyl, with Marcus Noland confirming that illicit shipments from China continue to fuel the opioid crisis in the United States. Simultaneously, Martin Chorzempa outlined tightening export‑control regimes as both nations vie for supremacy in emerging technologies such as AI and quantum computing. These dual pressures—security‑driven restrictions and health‑related enforcement—underscore the complexity of the bilateral agenda, where economic incentives intersect with national‑security imperatives.

For businesses and investors, the implications are clear: upcoming policy decisions will likely reflect a blend of economic pragmatism and strategic caution. Companies operating in high‑tech supply chains must monitor export‑control updates, while firms reliant on Sino‑U.S. trade should prepare for potential recalibrations in tariff structures. By grounding the summit’s discourse in empirical evidence, the briefing equips stakeholders with the insight needed to navigate an evolving geopolitical landscape and to align their strategies with the next phase of U.S.-China engagement.